Arkolith/Insider Trading/CDAK/Form 4

Flagship V VentureLabs Rx Fund, L.P.

10% OwnerCodiak BioSciences, Inc. (CDAK) · full profile →Form 4 · filed Sep 16, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2022Buy(P)723K——1.9M
Sep 15, 2022Buy(P)211K——1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2022Buy(P)211K——211K
Sep 15, 2022Buy(P)723K——723K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-031404) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML